245 related articles for article (PubMed ID: 9395525)
1. CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone.
Umayahara Y; Ji C; Centrella M; Rotwein P; McCarthy TL
J Biol Chem; 1997 Dec; 272(50):31793-800. PubMed ID: 9395525
[TBL] [Abstract][Full Text] [Related]
2. CCAAT/enhancer-binding protein delta is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts.
Umayahara Y; Billiard J; Ji C; Centrella M; McCarthy TL; Rotwein P
J Biol Chem; 1999 Apr; 274(15):10609-17. PubMed ID: 10187857
[TBL] [Abstract][Full Text] [Related]
3. Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts.
Thomas MJ; Umayahara Y; Shu H; Centrella M; Rotwein P; McCarthy TL
J Biol Chem; 1996 Sep; 271(36):21835-41. PubMed ID: 8702983
[TBL] [Abstract][Full Text] [Related]
4. Regulation of insulin-like growth factor I transcription by cyclic adenosine 3',5'-monophosphate (cAMP) in fetal rat bone cells through an element within exon 1: protein kinase A-dependent control without a consensus AMP response element.
McCarthy TL; Thomas MJ; Centrella M; Rotwein P
Endocrinology; 1995 Sep; 136(9):3901-8. PubMed ID: 7649098
[TBL] [Abstract][Full Text] [Related]
5. Hormonal control of insulin-like growth factor I gene transcription in human osteoblasts: dual actions of cAMP-dependent protein kinase on CCAAT/enhancer-binding protein delta.
Billiard J; Grewal SS; Lukaesko L; Stork PJ; Rotwein P
J Biol Chem; 2001 Aug; 276(33):31238-46. PubMed ID: 11390399
[TBL] [Abstract][Full Text] [Related]
6. 17beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures.
McCarthy TL; Ji C; Shu H; Casinghino S; Crothers K; Rotwein P; Centrella M
J Biol Chem; 1997 Jul; 272(29):18132-9. PubMed ID: 9218447
[TBL] [Abstract][Full Text] [Related]
7. Activation of the insulin-like growth factor-binding protein-5 promoter in osteoblasts by cooperative E box, CCAAT enhancer-binding protein, and nuclear factor-1 deoxyribonucleic acid-binding sequences.
Ji C; Chen Y; Centrella M; McCarthy TL
Endocrinology; 1999 Oct; 140(10):4564-72. PubMed ID: 10499512
[TBL] [Abstract][Full Text] [Related]
8. Time- and dose-related interactions between glucocorticoid and cyclic adenosine 3',5'-monophosphate on CCAAT/enhancer-binding protein-dependent insulin-like growth factor I expression by osteoblasts.
McCarthy TL; Ji C; Chen Y; Kim K; Centrella M
Endocrinology; 2000 Jan; 141(1):127-37. PubMed ID: 10614631
[TBL] [Abstract][Full Text] [Related]
9. Fos-related antigen 2 controls protein kinase A-induced CCAAT/enhancer-binding protein beta expression in osteoblasts.
Chang W; Rewari A; Centrella M; McCarthy TL
J Biol Chem; 2004 Oct; 279(41):42438-44. PubMed ID: 15299028
[TBL] [Abstract][Full Text] [Related]
10. Regulated nuclear-cytoplasmic localization of CCAAT/enhancer-binding protein delta in osteoblasts.
Billiard J; Umayahara Y; Wiren K; Centrella M; McCarthy TL; Rotwein P
J Biol Chem; 2001 May; 276(18):15354-61. PubMed ID: 11278589
[TBL] [Abstract][Full Text] [Related]
11. Runt domain factor (Runx)-dependent effects on CCAAT/ enhancer-binding protein delta expression and activity in osteoblasts.
McCarthy TL; Ji C; Chen Y; Kim KK; Imagawa M; Ito Y; Centrella M
J Biol Chem; 2000 Jul; 275(28):21746-53. PubMed ID: 10801838
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor activation integrates complex transcriptional effects in osteoblasts, involving the growth factors TGF-β and IGF-I, and transcription factor C/EBPδ.
McCarthy TL; Centrella M
Gene; 2015 Nov; 573(1):129-40. PubMed ID: 26187065
[TBL] [Abstract][Full Text] [Related]
13. Promoter-dependent and -independent activation of insulin-like growth factor binding protein-5 gene expression by prostaglandin E2 in primary rat osteoblasts.
McCarthy TL; Casinghino S; Mittanck DW; Ji CH; Centrella M; Rotwein P
J Biol Chem; 1996 Mar; 271(12):6666-71. PubMed ID: 8636084
[TBL] [Abstract][Full Text] [Related]
14. Activation domains of CCAAT enhancer binding protein delta: regions required for native activity and prostaglandin E2-dependent transactivation of insulin-like growth factor I gene expression in rat osteoblasts.
Ji C; Chang W; Centrella M; McCarthy TL
Mol Endocrinol; 2003 Sep; 17(9):1834-43. PubMed ID: 12791769
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 increases transforming growth factor-beta type III receptor expression through CCAAT enhancer-binding protein delta in osteoblasts.
McCarthy TL; Pham TH; Knoll BI; Centrella M
Mol Endocrinol; 2007 Nov; 21(11):2713-24. PubMed ID: 17636036
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 rapidly stimulates insulin-like growth factor-I gene expression in primary rat osteoblast cultures: evidence for transcriptional control.
Bichell DP; Rotwein P; McCarthy TL
Endocrinology; 1993 Sep; 133(3):1020-8. PubMed ID: 8396006
[TBL] [Abstract][Full Text] [Related]
17. Interactions between CCAAT enhancer binding protein delta and estrogen receptor alpha control insulin-like growth factor I (igf1) and estrogen receptor-dependent gene expression in osteoblasts.
Chang W; Parra M; Centrella M; McCarthy TL
Gene; 2005 Jan; 345(2):225-35. PubMed ID: 15716114
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CCAAT enhancer binding protein transcription factors in the regulation of prostaglandin G/H synthase 2 expression by interleukin-1 in osteoblastic MC3T3-E1 cells.
Harrison JR; Kelly PL; Pilbeam CC
J Bone Miner Res; 2000 Jun; 15(6):1138-46. PubMed ID: 10841183
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid suppression of IGF I transcription in osteoblasts.
Delany AM; Durant D; Canalis E
Mol Endocrinol; 2001 Oct; 15(10):1781-9. PubMed ID: 11579210
[TBL] [Abstract][Full Text] [Related]
20. Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells.
Pash JM; Delany AM; Adamo ML; Roberts CT; LeRoith D; Canalis E
Endocrinology; 1995 Jan; 136(1):33-8. PubMed ID: 7828549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
